| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.34 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |